ZA992596B - Azabicyclic 5HT1 receptor ligands. - Google Patents

Azabicyclic 5HT1 receptor ligands.

Info

Publication number
ZA992596B
ZA992596B ZA9902596A ZA992596A ZA992596B ZA 992596 B ZA992596 B ZA 992596B ZA 9902596 A ZA9902596 A ZA 9902596A ZA 992596 A ZA992596 A ZA 992596A ZA 992596 B ZA992596 B ZA 992596B
Authority
ZA
South Africa
Prior art keywords
azabicyclic
receptor ligands
ligands
receptor
Prior art date
Application number
ZA9902596A
Other languages
English (en)
Inventor
Gene Michael Bright
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of ZA992596B publication Critical patent/ZA992596B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10Drugs for genital or sexual disorders; Contraceptives for impotence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Reproductive Health (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Addiction (AREA)
  • Psychology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Child & Adolescent Psychology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Luminescent Compositions (AREA)
ZA9902596A 1998-04-09 1999-04-08 Azabicyclic 5HT1 receptor ligands. ZA992596B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8123798P 1998-04-09 1998-04-09

Publications (1)

Publication Number Publication Date
ZA992596B true ZA992596B (en) 2000-10-08

Family

ID=22162936

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9902596A ZA992596B (en) 1998-04-09 1999-04-08 Azabicyclic 5HT1 receptor ligands.

Country Status (41)

Country Link
US (2) US6525048B1 (hu)
EP (1) EP1070065B1 (hu)
JP (1) JP3496759B2 (hu)
KR (1) KR100378931B1 (hu)
CN (1) CN1117092C (hu)
AP (1) AP1175A (hu)
AR (1) AR015751A1 (hu)
AT (1) ATE248838T1 (hu)
AU (1) AU749254B2 (hu)
BG (1) BG104915A (hu)
BR (1) BR9909522A (hu)
CA (1) CA2327782A1 (hu)
CO (1) CO5080727A1 (hu)
CZ (1) CZ20003684A3 (hu)
DE (1) DE69910997T2 (hu)
DK (1) DK1070065T3 (hu)
DZ (1) DZ2756A1 (hu)
EA (1) EA003400B1 (hu)
ES (1) ES2204154T3 (hu)
HK (1) HK1035719A1 (hu)
HR (1) HRP20000653A2 (hu)
HU (1) HUP0102400A3 (hu)
ID (1) ID26086A (hu)
IL (1) IL138629A0 (hu)
IS (1) IS5641A (hu)
MA (1) MA26619A1 (hu)
MY (1) MY133390A (hu)
NO (1) NO20005004L (hu)
NZ (1) NZ507010A (hu)
OA (1) OA11496A (hu)
PA (1) PA8469101A1 (hu)
PE (1) PE20000413A1 (hu)
PL (1) PL343408A1 (hu)
PT (1) PT1070065E (hu)
SK (1) SK14782000A3 (hu)
TN (1) TNSN99056A1 (hu)
TR (1) TR200002932T2 (hu)
TW (1) TW555758B (hu)
WO (1) WO1999052907A1 (hu)
YU (1) YU59400A (hu)
ZA (1) ZA992596B (hu)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6231833B1 (en) 1999-08-05 2001-05-15 Pfizer Inc 2,7-substituted octahydro-1H-pyrido[1,2-A]pyrazine derivatives as ligands for serotonin receptors
UA62015C2 (en) * 1998-12-28 2003-12-15 Pfizer Prod Inc Benzoizoxazol derivatives, a pharmaceutical composition (variants) based thereon (variants) and a method for treatment (variants)
AU762934B2 (en) * 1999-09-03 2003-07-10 Allergan Sales, Llc Methods of using rapid-onset selective serotonin reuptake inhibitors for treating sexual dysfunction
GB2362826A (en) * 2000-06-02 2001-12-05 Lilly Co Eli A pharmaceutical composition comprising a serotonin transport inhibitor and a serotonin recptor antagonist
DE60229123D1 (de) * 2001-02-20 2008-11-13 Dinan Timothy Gerard Behandlung von fibromyalgie mit pindolol
MXPA05009660A (es) * 2003-03-12 2005-10-20 Pfizer Prod Inc Derivados azabiciclicos de piridiloximetilo y bencisoxazol.
WO2005082370A1 (en) * 2004-01-29 2005-09-09 Pfizer Products Inc. Combinations of an atypical antipsychotic and an aminomethylpyridyloxymethyl/benzisoxazole azabicyclic derivatives for treating cns disorders
JP4559749B2 (ja) * 2004-02-16 2010-10-13 あすか製薬株式会社 ピペラジニルピリジン誘導体
AR048112A1 (es) 2004-03-25 2006-03-29 Solvay Pharm Bv Derivados de 1-(2h-1-benzopiran-2-on-8-il)-piperazina para el tratamiento de dolor
AR049478A1 (es) 2004-03-25 2006-08-09 Solvay Pharm Bv Un procedimiento para la preparacion de 3-amino-8-(1-piperazinil)-2h-1-benzopiran-2-ona. sales e hidratos y composiciones farmaceuticas.
JP2008503560A (ja) * 2004-06-22 2008-02-07 ファイザー・プロダクツ・インク ジアザビシクロ系のヒスタミン−3受容体アンタゴニスト
EP2400300A1 (en) 2004-08-25 2011-12-28 Takeda Pharmaceutical Company Limited Method of screening preventives/remedies for stress urinary incontinence
BRPI0514793A (pt) * 2004-09-10 2008-06-24 Pfizer Prod Inc uso de derivados azabicìclicos de benzisoxazol e piridiloximetila na preparação de um medicamento para o tratamento de distúrbios cognitivos
US10154988B2 (en) 2012-11-14 2018-12-18 The Johns Hopkins University Methods and compositions for treating schizophrenia
WO2020183011A1 (en) 2019-03-14 2020-09-17 Institut Curie Htr1d inhibitors and uses thereof in the treatment of cancer

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5106849A (en) * 1988-05-24 1992-04-21 American Home Products Corporation Use of aryl- and heteroaryl piperazinyl carboxamides in the treatment of various central nervous system disorders
WO1990008148A1 (en) * 1989-01-23 1990-07-26 Pfizer Inc. Bis-aza-bicyclic anxiolytic agents
US5157034A (en) * 1991-02-27 1992-10-20 Pfizer Inc. Neuroleptic perhydro-1H-pyrido[1,2-a]pyrazines
CA2118936A1 (en) * 1991-09-25 1993-04-01 Gene M. Bright Neuroleptic 2-substituted perhydro-1-h-pyrido[1,2-a]pyrazines
US5262428A (en) * 1992-03-13 1993-11-16 Wake Forest University Biologically active tropane derivatives
JP2753146B2 (ja) * 1992-06-16 1998-05-18 ファイザー・インコーポレーテッド ビス−アザー二環式抗不安薬の製法および中間体
GB9410512D0 (en) * 1994-05-25 1994-07-13 Smithkline Beecham Plc Novel treatment
WO1996010570A1 (en) * 1994-09-30 1996-04-11 Pfizer Inc. NEUROLEPTIC 2,7-DISUBSTITUTED PERHYDRO-1H-PYRIDO[1,2-a]PYRAZINES
US5614523A (en) * 1995-01-17 1997-03-25 Eli Lilly And Company Compounds having effects on serotonin-related systems

Also Published As

Publication number Publication date
EA200000910A1 (ru) 2001-04-23
HRP20000653A2 (en) 2001-04-30
KR20010042527A (ko) 2001-05-25
DE69910997D1 (de) 2003-10-09
DK1070065T3 (da) 2003-11-24
TW555758B (en) 2003-10-01
AP9901502A0 (en) 1999-06-30
ID26086A (id) 2000-11-23
JP2002511469A (ja) 2002-04-16
NO20005004L (no) 2000-11-27
AU3268799A (en) 1999-11-01
US20030181458A1 (en) 2003-09-25
CO5080727A1 (es) 2001-09-25
HUP0102400A3 (en) 2002-10-28
ES2204154T3 (es) 2004-04-16
OA11496A (en) 2004-05-14
CA2327782A1 (en) 1999-10-21
US6887905B2 (en) 2005-05-03
PT1070065E (pt) 2003-12-31
NO20005004D0 (no) 2000-10-04
AR015751A1 (es) 2001-05-16
DZ2756A1 (fr) 2003-09-15
US6525048B1 (en) 2003-02-25
HUP0102400A2 (hu) 2001-11-28
PA8469101A1 (es) 2000-09-29
IL138629A0 (en) 2001-10-31
TR200002932T2 (tr) 2001-01-22
CN1305477A (zh) 2001-07-25
AU749254B2 (en) 2002-06-20
PE20000413A1 (es) 2000-05-25
HK1035719A1 (en) 2001-12-07
EP1070065B1 (en) 2003-09-03
ATE248838T1 (de) 2003-09-15
TNSN99056A1 (fr) 2005-11-10
BG104915A (en) 2001-07-31
NZ507010A (en) 2003-05-30
WO1999052907A1 (en) 1999-10-21
BR9909522A (pt) 2000-12-19
DE69910997T2 (de) 2004-05-19
SK14782000A3 (sk) 2002-06-04
PL343408A1 (en) 2001-08-13
JP3496759B2 (ja) 2004-02-16
EA003400B1 (ru) 2003-04-24
MA26619A1 (fr) 2004-12-20
CN1117092C (zh) 2003-08-06
CZ20003684A3 (cs) 2002-03-13
AP1175A (en) 2003-06-04
MY133390A (en) 2007-11-30
KR100378931B1 (ko) 2003-04-07
YU59400A (sh) 2003-10-31
EP1070065A1 (en) 2001-01-24
IS5641A (is) 2000-09-26

Similar Documents

Publication Publication Date Title
HUP0104666A3 (en) Thyroid receptor ligands
GB9808229D0 (en) Melanocortin receptor ligands
EG24814A (en) Novel compounds.
ZA200107411B (en) Melanocortin receptor ligands.
HK1033126A1 (en) Non-steroidal ligands for the estrogen receptor.
ZA985678B (en) 1-amino-alkylcyclohexane NMDA receptor antagonists.
HK1047925A1 (en) Aniline-derived ligands for the thyroid receptor.
ZA200005136B (en) Dihydropyrimides.
GB9810671D0 (en) Anti-pruritic agents
ZA992596B (en) Azabicyclic 5HT1 receptor ligands.
EP1084142A4 (en) GPR35A RECEIVER
AU5671699A (en) Grp receptor ligands
HK1038887A1 (zh) C3a受體配基
SI1070065T1 (en) Azabicyclic 5ht1 receptor ligands
EP1083909A4 (en) hCEPR RECEPTOR
GB9803062D0 (en) Estrogen receptor ligands
ZA977445B (en) Troponyl piperazines as dopamine D4 receptor ligands.
GB9815373D0 (en) Receptor ligands
EP1109565A4 (en) GABAB1AA RECEPTOR
ZA993401B (en) Formamidinesulfinic-acid blends II.
ZA200003475B (en) Muscarinic receptor antagonists.
GB9825849D0 (en) Receptor
ZA986876B (en) 1-Phenyl-4-benzylpiperazines; dopamine receptor subtype specific ligands.
ZA9610758B (en) Bucket for mopping.
GB9920046D0 (en) Novel receptor/ligand